Dexa Group
From Molecule,
to Market
Five decades of end-to-end expertise in pharmaceutical discovery, formulation, manufacturing, and marketing — across Southeast Asia and the Asia Pacific.
Awards Earned
Primaniyarta
Award
Ministry
of Trade
of Trade
2005 • 2017-2019 • 2021
Indonesia's Most
Admired Companies
Warta
Ekonomi
Ekonomi
2017-2019
Top Brand
for Kids
Marketing
Magazine
Magazine
2009-2020 • 2022
Outstanding Corporate
Innovator
Product Development and
Management Association
Management Association
2018
IIRDI
Award
Ministry of Research
and Technology
and Technology
2018-2019
BPOM
Award
Food and Drug
Agency Indonesia
Agency Indonesia
2017
Dexa means Quality
Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.
Our Companies
Indonesian Modern Herbal Medicines
We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.
Dexa: A Snapshot
Employees
Patents
Trademarks
Pharmacies Covered Directly
International Alliances
Marketing Authorisations
Latest News
6 March 2023
Dexa Group Wins the Indonesia Corporate Public Relations Award for the 5th time
Dexa Group was awarded The Best Indonesia Public Relations in the Health Sector by the Indonesia Corporate Public Relation Awards (IPRA) 2023. Dexa Group has won the IPRA Award for the fifth time since 2018. With the theme “Winning Economic Growth Through Consistent Collaboration", IPRA 2023 is being held to…
16 January 2023
BPOM and Dexa Group Collaborate to Educate the Public on Good Manufacturing Practice
Domestic pharmaceutical industry with international standard, Dexa Group participated in Expo of Food and Drug Life Cycle Product Supervision held by The Indonesian National Agency of Drug and Food Control (Badan POM). This event is an educational event from Badan POM as the regulator and the pharmaceutical and food industry…
16 December 2022
Dexa Group's CEO Named Indonesia Most Acclaimed CEO 2022
For his leadership that has allowed the company to adapt successfully, make breakthroughs, and continue to make developments to provide a positive stimulant to the economy in Indonesia, Dexa Group CEO Mr. Ferry Soetikno was awarded the Indonesia Most Acclaimed CEO 2022 in the pharmaceutical category from WartaEkonomi.co. id. Indonesia…
12 December 2022
Committed to Accelerating the Halal Industry, Dexa Group Achieved Indonesia Halal Industry Awards 2022
As a pioneer in the implementation of research for the Indonesia Indigenous Modern Medicine (OMAI) products certified by the Halal Product Assurance System, Dexa Group has achieved the Indonesia Halal Industry Award (IHYA) 2022 for the Best Halal Innovation category. The award held by the Ministry of Industry of the…
16 November 2022
Figures of Indonesia Indigenous Modern Medicine Receive Honorary Title of Adjunct Professorship from Atma Jaya Catholic University
Dr. Raymond Rubianto Tjandrawinata, a leading figure in Indonesia Indigenous Modern Medicine (OMAI), was awarded the honorary title of Adjunct Professor in Pharmaceutical Biotechnology by the Indonesian Catholic University (Unika) Atma Jaya Jakarta. Dr. Raymond Rubianto Tjandrawinata has demonstrated a scientific discovery and contribution to the advancement of pharmaceutical biotechnology,…
4 November 2022
Dexa Group's Strategic Support for Indonesian Pharmacy Resilience and Independence: Indonesia Indigenous Modern Medicine Phytopharmaceutical
The pharmaceutical business is still working toward independence and health security due to the changes in the market brought on by the pandemic circumstances, the global financial crisis, and the high US Dollar exchange rate against the Rupiah. Dexa Group presented three significant initiatives for pharmaceutical resilience and independence with…